HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and ...

Collaboration will combine AbbVie’s oncology expertise and Xilio’s proprietary tumor-activation technology to develop novel immunotherapies, ...

Regeneron Pharmaceuticals, Inc. and CytomX Therapeutics, Inc. have announced a strategic research collaboration within the field of conditionally activated ... such as cytokines and checkpoint ...

This innovative therapy aims to enhance anti-tumor efficacy by inducing a strong localized immu CAPTN-3 is a conditionally activated tri-specific antibody platform that features novel dual ...

Last week, Regeneron announced a strategic research collaboration with CytomX Therapeutics within the field of conditionally activated bispecific therapeutics for the treatment of cancer.

On Wednesday, JMP Securities initiated coverage on Werewolf Therapeutics Inc. (NASDAQ:HOWL) stock with a Market Outperform rating and set a price target of $12.00. The firm ...

Activated charcoal has been used to treat poisoning for centuries but may have other health benefits as well. This fine, odorless, black powder is produced by heating charcoal to an extremely high ...

Results M1 but not M2-polarised macrophages accumulated in human and mouse OA synovial tissue. TSC1 deletion in the myeloid lineage constitutively activated mechanistic target of rapamycin complex 1 ...